These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9020020)

  • 21. Telomerase, checkpoints and cancer.
    Harley CB; Sherwood SW
    Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Telomere and telomerase].
    Ishikawa F
    Hum Cell; 1996 Dec; 9(4):287-94. PubMed ID: 9183660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
    Klingelhutz AJ
    Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of telomere-binding proteins in carcinogenesis].
    Aragona M; Pontoriero A; Panetta S; La Torre I; La Torre F
    Minerva Med; 2000; 91(11-12):299-304. PubMed ID: 11253711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple pathways for the regulation of telomerase activity.
    Holt SE; Wright WE; Shay JW
    Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human senescence, cancer and telomerase].
    Ide T; Tahara H
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(9):1351-74. PubMed ID: 9216229
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection against chromosome degradation at the telomeres.
    Grandin N; Charbonneau M
    Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
    Bitisik O; Yavuz S; Yasasever V; Dalay N
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cancer as a microevolutionary process affecting telomere structure and dynamics: the contribution of telomeres to cancer].
    Londono-Vallejo JA
    Ai Zheng; 2008 Jul; 27(7):775-83. PubMed ID: 18606076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere maintenance in clinical medicine.
    Ulaner GA
    Am J Med; 2004 Aug; 117(4):262-9. PubMed ID: 15308436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomeres rather than telomerase a key target for anti-cancer therapy?
    Boukamp P; Mirancea N
    Exp Dermatol; 2007 Jan; 16(1):71-9. PubMed ID: 17181645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of telomeres and telomerase in the pathology of human cancer and aging.
    Shin JS; Hong A; Solomon MJ; Lee CS
    Pathology; 2006 Apr; 38(2):103-13. PubMed ID: 16581649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.
    Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC
    Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere length maintenance--an ALTernative mechanism.
    Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
    Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomeres and telomerase in cancer stem cells.
    Ju Z; Rudolph KL
    Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase as a clinical target: current strategies and potential applications.
    Fleisig HB; Wong JM
    Exp Gerontol; 2007; 42(1-2):102-12. PubMed ID: 16814507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.